HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A.

AuthorsYohann Repessé, Catherine Costa, Roberta Palla, Elika Farrokhi Moshai, Annie Borel-Derlon, Roseline D'Oiron, Chantal Rothschild, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Johannes Oldenburg, Anna Pavlova, Frits R Rosendaal, Flora Peyvandi, Srinivas V Kaveri, Sébastien Lacroix-Desmazes
JournalHaematologica (Haematologica) Vol. 104 Issue 8 Pg. e369-e372 (08 2019) ISSN: 1592-8721 [Electronic] Italy
PMID30705098 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Isoantibodies
  • von Willebrand Factor
  • F8 protein, human
  • Factor VIII
Topics
  • Alleles
  • Area Under Curve
  • Factor VIII (adverse effects, metabolism, therapeutic use)
  • Genotype
  • Hemophilia A (diagnosis, drug therapy, immunology, metabolism)
  • Humans
  • Isoantibodies (immunology)
  • Polymorphism, Single Nucleotide
  • ROC Curve
  • von Willebrand Factor (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: